References
- Roth GA, Abate D, Abate KH et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159), 1736–1788 (2018).
- Brown JC, Gerhardt TE, Kwon E. Risk factors for coronary artery disease. In: StatPearls. StatPearls Publishing, Treasure Island, FL, USA (2022).
- Hossein-nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin. Proc. 88(7), 720–755 (2013).
- Ganji V, Zhang X, Tangpricha V. Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J. Nutr. 142(3), 498–507 (2012).
- Greene-Finestone LS, Berger C, de Groh M et al. 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos. Int. 22(5), 1389–1399 (2011).
- Cashman KD, Dowling KG, Škrabáková Z et al. Vitamin D deficiency in Europe: pandemic? Am. J. Clin. Nutr. 103(4), 1033–1044 (2016).
- Płudowski P, Ducki C, Konstantynowicz J, Jaworski M. Vitamin D status in Poland. Pol. Arch. Med. Wewn. 126(7–8), 530–539 (2016).
- Gondim F, Caribé A, Vasconcelos KF et al. Vitamin D deficiency is associated with severity of acute coronary syndrome in patients with Type 2 Diabetes and high rates of sun exposure. Clin. Med. Insights Endocrinol. 9, 37–41 (2016).
- Al Mheid I, Quyyumi AA. Vitamin D and cardiovascular disease. J. Am. Coll. Cardiol. 70(1), 89–100 (2017).
- Patel U, Yousuf S, Lakhani K et al. Prevalence and outcomes associated with vitamin D deficiency among indexed hospitalizations with cardiovascular disease and cerebrovascular disorder - a nationwide study. Medicine (Basel) 7(11), E72 (2020).
- Kusunose K, Okushi Y, Okayama Y et al. Association between vitamin D and heart failure mortality in 10,974 hospitalized individuals. Nutrients 13(2), 335 (2021).
- Płudowski P, Kos-Kudła B, Walczak M et al. Guidelines for preventing and treating vitamin D deficiency: a 2023 update in Poland. Nutrients 15(3), 695 (2023).
- Gezen-Ak D, Atasoy IL, Candaş E, Alaylioglu M, Yılmazer S, Dursun E. Vitamin D receptor regulates amyloid beta 1–42 production with protein disulfide isomerase A3. ACS Chem. Neurosci. 8(10), 2335–2346 (2017).
- Abouzid M, Główka AK, Karaźniewicz-Łada M. Trend research of vitamin D receptor: bibliometric analysis. Health Informatics J. 27(4), 14604582211043158 (2021).
- Berridge MJ. Vitamin D cell signalling in health and disease. Biochem. Biophys. Res. Commun. 460(1), 53–71 (2015).
- Condoleo V, Pelaia C, Armentaro G et al. Role of vitamin D in cardiovascular diseases. Endocrines 2(4), 417–426 (2021).
- Martinez-Moreno JM, Herencia C, Montes de Oca A et al. Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells. FASEB J. 30(3), 1367–1376 (2016).
- Jamali N, Sorenson CM, Sheibani N. Vitamin D and regulation of vascular cell function. Am. J. Physiol. Heart Circ. Physiol. 314(4), H753–H765 (2018).
- Yao T, Ying X, Zhao Y et al. Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy. Antioxid. Redox Signal. 22(8), 633–650 (2015).
- Wei H, Qu H, Wang H et al. 1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the β-catenin/TCF4/GSK-3β/mTOR pathway. J. Steroid Biochem. Mol. Biol. 168, 71–90 (2017).
- Ortlepp JR, von Korff A, Hanrath P, Zerres K, Hoffmann R. Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur. J. Clin. Invest. 33(2), 106–109 (2003).
- González Rojo P, Pérez Ramírez C, Gálvez Navas JM et al. Vitamin D-related single nucleotide polymorphisms as risk biomarker of cardiovascular disease. Int. J. Mol. Sci. 23(15), 8686 (2022).
- Akhlaghi B, Firouzabadi N, Foroughinia F, Nikparvar M, Dehghani P. Impact of vitamin D receptor gene polymorphisms (TaqI and BsmI) on the incidence and severity of coronary artery disease: a report from southern Iran. BMC Cardiovasc. Disord. 23(1), 113 (2023).
- He L, Wang M. Association of vitamin D receptor-A gene polymorphisms with coronary heart disease in Han Chinese. Int. J. Clin. Exp. Med. 8(4), 6224–6229 (2015).
- Laczmanski L, Milewicz A, Lwow F et al. Vitamin D receptor gene polymorphism and cardiovascular risk variables in elderly Polish subjects. Gynecol. Endocrinol. 29(3), 268–272 (2013).
- Abouzid M, Kruszyna M, Burchardt P, Kruszyna Ł, Główka FK, Karaźniewicz-Łada M. Vitamin D receptor gene polymorphism and vitamin D status in population of patients with cardiovascular disease–a preliminary study. Nutrients 13(9), 3117 (2021).
- Knuuti J, Wijns W, Saraste A et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the Diagnosis and Management of Chronic Coronary Syndromes of the European Society of Cardiology (ESC). Eur. Heart J. 41(3), 407–477 (2020).
- Lips P, Cashman KD, Lamberg-Allardt C et al. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur. J. Endocrinol. 180(4), P23–P54 (2019).
- Abouzid M, Karaźniewicz-Łada M, Pawlak K, Burchardt P, Kruszyna Ł, Główka F. Measurement of plasma 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in population of patients with cardiovascular disease by UPLC-MS/MS method. J. Chromatogr. B 1159, 122350 (2020).
- Untergasser A, Cutcutache I, Koressaar T et al. Primer3–new capabilities and interfaces. Nucleic Acids Res. 40(15), e115 (2012).
- De La Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, Lavie CJ, Sanchis-Gomar F, Pareja-Galeano H. Vitamin D and cardiovascular health. Clin. Nutr. 40(5), 2946–2957 (2021).
- Jiang W-L, Gu H-B, Zhang Y-F, Xia Q-Q, Qi J, Chen J-C. Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin. Cardiol. 39(1), 56–61 (2016).
- Zhao J-D, Jia J-J, Dong P-S et al. Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials. BMJ Open 8(8), e020545 (2018).
- Wang T, Liu Z, Fu J, Min Z. Meta-analysis of vitamin D supplementation in the treatment of chronic heart failure. Scand. Cardiovasc. J. SCJ 53(3), 110–116 (2019).
- Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 27(10), 1948 (2009).
- Pandit A, Mookadam F, Boddu S et al. Vitamin D levels and left ventricular diastolic function. Open Heart 1(1), e000011 (2014).
- Iwahashi N, Gohbara M, Abe T et al. Clinical significance of late diastolic tissue doppler velocity at 24 hours or 14 days after onset of ST-elevation acute myocardial infarction. Circ. Rep. 3(7), 396–404 (2021).
- Siasos G, Tousoulis D, Oikonomou E et al. Vitamin D3, D2 and arterial wall properties in coronary artery disease. Curr. Pharm. Des. 20(37), 5914–5918 (2014).
- Keen J, Prisco SZ, Prins KW. Sex differences in right ventricular dysfunction: insights from the bench to bedside. Front. Physiol. 11, 623129 (2021).
- Lu S, Guo S, Hu F et al. The associations between the polymorphisms of vitamin D receptor and coronary artery disease: a systematic review and meta-analysis. Medicine (Baltimore) 95(21), e3467 (2016).
- Alizadeh S, Djafarian K, Alizadeh H, Mohseni R, Shab-Bidar S. Common variants of vitamin D receptor gene polymorphisms and susceptibility to coronary artery disease: a systematic review and meta-analysis. J. Nutr. 10(1–2), 9–18 (2017).
- Lutsey PL, Alonso A, Michos ED et al. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study1,2,3. Am. J. Clin. Nutr. 100(3), 756–764 (2014).
- Zittermann A, Ernst JB, Prokop S et al. Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trial. Int. J. Cardiol. 280, 117–123 (2019).
- Mulè G, Nardi E, Morreale M et al. The relationship between aortic root size and hypertension: an unsolved conundrum. In: Hypertension: From Basic Research to Clinical Practice (Volume 956). Islam MdS ( Ed.). Springer International Publishing, Cham, Switzerland, 427–445 (2016).
- Abouzid M, Główka F, Karaźniewicz-Łada M. Seasonal pattern of vitamin D hydroxyl metabolite concentrations and their association with cardiac medications–an observational study. J. King Saud. Univ. Sci. 34(6), 102187 (2022).